Browse studies, page 1209
Page 1209 of 1,286, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Abstract 3482: Correlative analysis of metformin and nivolumab combination in treatment-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC) Cancer Research, 2022
- Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis Scientific Reports, 2020
- Efficacy of Metformin in Patients With Breast Cancer Receiving Chemotherapy or Endocrine Therapy: Systematic Review and Meta-analysis The Annals of Pharmacotherapy, 2021
- The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis Reproductive Biology and Endocrinology, 2021
- Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials Frontiers in Endocrinology, 2022
- Comparison of the effects on cardiovascular events between use of metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycaemic agents in Japanese patients with type 2 diabetes mellitus: a claims database analysis BMJ Open, 2022
- Systematic review and meta-analysis of Coptis chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus Frontiers in Pharmacology, 2022
- Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial Nature Communications, 2025
- Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis Frontiers in Pharmacology, 2022
- Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis International Journal of Gynecological Cancer, 2021
- Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis Frontiers in Medicine, 2021
- Characterization of changes in HbA1c in patients with and without secondary failure after metformin treatments by a population pharmacodynamic analysis using mixture models Drug Metabolism and Pharmacokinetics, 2018
- Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus BMJ Open Diabetes Research & Care, 2021
- Different effects of metformin and insulin on primary and secondary chemoprevention of colorectal adenoma in diabetes type 2: Traditional and Bayesian meta-analysis EXCLI Journal : Experimental and Clinical Sciences, 2018
- SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise Clinical science, 2020
- Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials BMJ Open, 2023
- Prescription patterns and therapeutic effects of second-line drugs in Japanese patients with type 2 diabetes mellitus: Analysis of claims data for metformin and dipeptidyl peptidase-4 inhibitors as the first-line hypoglycemic agents Expert Opinion on Pharmacotherapy, 2023
- Comparative effects of acupuncture and metformin on insulin sensitivity in overweight/obese and lean women with polycystic ovary syndrome and insulin resistance: a post hoc analysis of a randomized trial Frontiers in Medicine, 2023
- Neoadjuvant metformin on clinical and pathological response in non-diabetic patients with non-metastatic breast cancer: an updated systematic review and meta-analysis Clinical and Translational Oncology, 2026
- Effectiveness of Metformin in Preventing Type 2 Diabetes in Children and Adolescents with Overweight or Obesity: A Protocol for a Systematic Review and Meta-Analysis Obesities, 2026
- Revisiting metformin as a chemotherapy adjuvant: a systematic review and meta-analysis based on recent randomized-controlled trials Frontiers in Oncology, 2026
- Impact of metformin on outcomes with immune checkpoint inhibitors in renal cell carcinoma: A large-scale retrospective analysis Journal of Clinical Oncology, 2026
- Evaluation of Jinlida Granules in Improvements to Standard-Reaching Rate of Blood Glucose and Type 2 Diabetes Mellitus Symptoms: Results of Secondary Analysis From 12-Week Trial 2021
- Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2024
- Metformin use and preeclampsia risk in women with diabetes: a two-country cohort analysis BMC Medicine, 2024
- Metformin Use in Type 2 Diabetics and Delirium After Noncardiac Surgery: A Retrospective Cohort Analysis Anesthesia and Analgesia, 2024
- Efficacy of Metformin for the Treatment of Melasma: A Systematic Review and Meta-analysis of Randomised Controlled Trials Journal of Advanced Trends in Medical Research, 2025
- Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort Diabetes & metabolic syndrome, 2023
- Pioglitazone as Add-On to Metformin and Dapagliflozin Yields Significant Enhancements in Glycemic Control in Poorly Controlled Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials Cureus, 2025
- Effectiveness of Glipizide and Glipizide Plus Metformin Formulation among Asian Indians with Type 2 Diabetes: a Real‐World, Retrospective Electronic Medical Record Analysis Drugs - Real World Outcomes, 2025
- Abstract P131: Individualized Risk Prediction for Type 2 Diabetes: A Secondary Analysis of the Diabetes Prevention Program Circulation, 2024
- Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial Journal of Clinical Oncology, 2024
- Lactic acidosis secondary to metformin toxicity :a case report Endocrine Abstracts, 2025
- Insulin clearance at randomization and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomized clinical trial Diabetologia, 2024
- 546-P: Effects of Metformin on Heart Rate Variability in Adolescents with Type 1 Diabetes: A Secondary Analysis of a Randomized Crossover-Controlled Trial 2020
- Prices of Anti-Diabetic Drugs Sold in Private Pharmacies in Côte d’Ivoire, 2023: A Secondary Analysis ClinicoEconomics and Outcomes Research, 2025
- Breastfeeding patterns among parturients with diabetes: A secondary analysis of the MOMPOD randomized clinical trial Pregnancy, 2025
- Metformin's therapeutic potential in spinal cord injury: a systematic review and meta-analysis on locomotor recovery, neuropathic pain alleviation, and modulation of secondary injury mechanisms Acta Neurochirurgica, 2025
- Early Metformin for Gestational Diabetes Mellitus Does Not Alter Exclusive Breastfeeding at 12 Weeks: Secondary Analysis of the EMERGE Randomized Trial Diabetes Obesity and Cardiometabolic CARE, 2026
- Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302 European Journal of Cancer, 2022
- Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trial Chinese Medical Journal - Pulmonary and Critical Care Medicine, 2023
- Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial Frontiers in Endocrinology, 2023
- Postnatal Cardiometabolic Health After Metformin Use in Gestational Diabetes: A Secondary Analysis of the EMERGE Trial Journal of Clinical Endocrinology and Metabolism, 2024
- Longitudinal associations of dietary fiber and its source with 48-week weight loss maintenance, cardiometabolic risk factors and glycemic status under metformin or acarbose treatment: a secondary analysis of the March randomized trial Nutrition & Diabetes, 2024
- Glucagon-like receptor-1 agonists and impotence: A meta-analysis World journal of methodology, 2026
- The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care Clinical journal of the American Society of Nephrology : CJASN, 2026
- Effects of GLP-1 Receptor Agonists vs Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Cureus, 2026
- Comparative cardiovascular outcomes and safety of hypoglycemic drug classes in patients with type 2 diabetes and hypertension: a multicenter cohort analysis Cardiovascular diabetology, 2025
- Correlations between metformin and prognosis and adverse reactions in patients undergoing radical cystectomy followed by adjuvant GC chemotherapy for bladder cancer BMC cancer, 2026
- Safety and efficacy of metformin for the treatment of pain: protocol for a systematic review BMJ open, 2026
- Association Between Oral Antihyperglycemic Medications and Erectile Function in Men with Type 2 Diabetes Mellitus Life (Basel, Switzerland), 2026
- CGM-based metrics and mortality in older adults living with type 2 diabetes on insulin therapy: a secondary analysis of the HYPOAGE study Diabetes & metabolism, 2026
- Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception Cardiovascular diabetology, 2026
- Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populations BMC nephrology, 2025
- SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications Drugs in context, 2026
- Targeting a hypothetical estimand based on adherence with the parametric g-formula: A post hoc secondary analysis of the MET-PREVENT randomised controlled trial medRxiv, 2025
- Empagliflozin and its impact on hepatic and metabolic outcomes in patients with type 2 diabetes and NAFLD: a systematic review and meta-analysis Diabetology & metabolic syndrome, 2026
- Effects of Metformin Monotherapy Versus Metformin Plus SGLT-2 Inhibitor Therapy on Molecular and Cellular Inflammatory Markers in Patients with Newly Diagnosed Type 2 Diabetes Mellitus Journal of clinical medicine, 2026
- Clinical and Dermoscopic Evaluation of the Effectiveness of Metformin versus Pioglitazone in Acanthosis Nigricans: A Randomised Controlled Trial Indian dermatology online journal, 2026
- The effects of metformin and exercise training on cardiorespiratory, blood pressure, and metabolic adaptations across the spectrum of glucose dysregulation: a systematic review and meta-analysis EClinicalMedicine, 2026
- Tirzepatide as an Add-on for Participants with Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6 Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
- Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease International journal of nephrology and renovascular disease, 2026
- Long-term stability of the triglyceride-glucose index in cancer patient Cohort Scientific reports, 2026
- Taurine reduces intracellular glucose accumulation in fructose-treated Caenorhabditis elegans Amino acids, 2026
- Betanin Modulates the Leptin-Adiponectin Axis and Improves Glycemic Control in a High-Fat Diet and Streptozotocin-Induced Rat Model of Type 2 Diabetes Cureus, 2026
- Immunological Drug-Drug Interactions in Immune Checkpoint Inhibitor Therapy: Mechanisms, Clinical Evidence, and Artificial Intelligence Current oncology reports, 2026
- Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD) Frontiers in pharmacology, 2026
- Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli-D Study Diabetes, obesity & metabolism, 2026
- Withholding or continuing glucose-lowering drugs for elective surgery in patients with type 2 diabetes mellitus: a secondary analysis of the MOPED international, prospective, observational study British journal of anaesthesia, 2026
- Observational studies on the association of outpatient antidiabetic medication use and COVID-19 outcomes: are the findings more relevant to diabetes management than to COVID-19 pathology? A mini-review Frontiers in clinical diabetes and healthcare, 2026
- Mechanistic Insights Into the Cardioprotective Effects of Modern Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review Cureus, 2025
- Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation Hepatology international, 2026
- Dorema Aucheri Extract Modulates Unfolded Protein Response Pathways in Streptozotocin-Induced Diabetic Rats: A Protective Role Against Hepatic Damage International journal of endocrinology, 2026
- Metformin and Hypertensive Disorders of Pregnancy: A Phenotype-Based Focused Narrative Review Journal of clinical medicine, 2026
- Comparative response to pharmacological management of asthma in overweight/obese children versus their counterparts: a systematic review and call for data European respiratory review : an official journal of the European Respiratory Society, 2026
- The Extent and Phenotype of Coronary Artery Disease in Diabetes and Prediabetes: Insights From Imaging Studies and Potential Therapeutic Implications Reviews in cardiovascular medicine, 2026
- Metformin and Flutamide Combination Therapy's Efficacy and Safety in Prostate Cancer Cell Lines Prostate cancer, 2026
- LAP-defined hepatic steatosis and cardiometabolic risk in rheumatoid arthritis: a post-hoc analysis of the FRANCIS randomized trial Rheumatology international, 2026
- Cardioprotective effect of diabetic medication on cancer patients undergoing proven cardiotoxic chemotherapy: a systematic review and meta-analysis Cardio-oncology (London, England), 2026
- Combination of GLP-1 receptor agonists and SGLT2 inhibitors in cardiometabolic disease: synergistic, additive, or non-additive effects? A narrative review Cardiovascular diabetology, 2026
- Glucagon-like peptide-1 receptor agonists and risk of depression: a systematic review and meta-analysis BMC psychiatry, 2026
- Effectiveness of GLP-1 Receptor Agonists in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials Cureus, 2026
- Circulating propionate and butyrate are associated with metabolic improvements following probiotic and dietary fiber supplementation in patients on antipsychotics: a post-hoc analysis of a randomized controlled trial BMC psychiatry, 2026
- Co-prescription of metformin and glucagon-like peptide-1 receptor agonists and metformin-associated lactic acidosis: A case series Clinical nephrology. Case studies, 2026
- CGM-derived postprandial glucose with IcoSema versus other insulin regimens: a post hoc analysis of COMBINE 1 and 3 EClinicalMedicine, 2026
- Meta-Analysis of the Effect of Metformin on the Progression of Different Types of Prediabetes Mellitus Diabetes, metabolic syndrome and obesity : targets and therapy, 2026
- Evidence of a Protective Effect of Metformin on Abdominal Aortic Aneurysm Risk: Insights From an Observational Study and Mendelian Randomisation Analysis Using Putative Metformin Targets Annals of human genetics, 2026
- Efficacy and safety of metformin versus empagliflozin on chronic kidney disease progression (MET-EMPA-CKD): a randomized controlled trial Diabetology & metabolic syndrome, 2025
- iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China Diabetes, obesity & metabolism, 2025
- Effects of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors on Lipid Profiles in Type 2 Diabetes: A Systematic Review Cureus, 2026
- Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review Endocrinology, diabetes & metabolism, 2026
- Metabolic-Protective Strategies for Antipsychotic-Associated Weight Gain in Children and Adolescents: A Systematic Review Cureus, 2026
- Clinical characteristics of Sarcopenic obesity in Japanese people with type 2 diabetes: A post hoc analysis of the sub-cohort iDIAMOND study Journal of diabetes investigation, 2026
- Association of metformin with lung function decline and mortality in fibrotic interstitial lung disease: an observational cohort study Respiratory research, 2026
- Predictors of Initial and Sustained Glycemic and Weight Response to Tirzepatide: A Post Hoc Analysis of SURPASS-4 Diabetes, 2025
- Metformin and insulin exacerbate one-carbon metabolism deficits in pregnant growth restricted rats and impacts the placenta, fetal liver and pancreas The Journal of physiology, 2025
- 11-Oxygenated Androgens in Pcos: Impact of Pcos Phenotypes and First-Line Interventions The Journal of clinical endocrinology and metabolism, 2026
- Evaluating Cost-Effectiveness in Relation to the Supporting Clinical Evidence Across the Type 2 Diabetes Continuum: A Review of Metformin and SGLT2is Advances in therapy, 2026
- Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK. Journal of medical economics, 2026
- Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Use in Elderly People With Obesity-A Meta-Analysis Obesity (Silver Spring, Md.), 2026
